|
|
 |
|
|
|
 |
|
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
3. This submission is within which of the following therapeutic area(s)
|
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
8. What toxicological data are available?
|
|
 |
|
|
 |
|
 |
If yes
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
What regions are covered by patents?
|
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
|
|
 |
|
 |
Please write us with a brief, non-confidential description of the opportunity covering the following:
- Goals of the proposed collaborative program.
- Main scientific and technology approaches pursued.
- Sufficient scientific and therapeutic discovery data to support the proposal.
- Listing of key in vivo experimental models used.
- Existing collaborations in the field.
Please note that if you divulge information to us that is not already the subject of a filed patent application, such disclosure may be considered a publication and may jeopardize patent applications in the future.
Please send your proposal to:
Chief Licensing Officer
WS2A-39, One Merck Drive
P. O. Box 100
Merck & Co., Inc.
Whitehouse Station, NJ 08889, USA
By accepting this disclosure agreement, I represent and warrant that I have the authority to disclose information under the conditions of this Agreement. As used below, the "Company" means Merck & Co., Inc., and any company affiliated with it. I acknowledge that I make this submission voluntarily. I agree that no confidential relationship is established or implied by the Company's acceptance or evaluation of the submitted material, and that the Company shall have the right to retain any such material. The Company shall not be obligated to specify the reasons for any decision it makes regarding the idea or to reveal any past or present activities that relate to the idea.
We look forward to hearing from you!
|
 |
| * Indicates required field |
 |
|
|
 |